Clinical Trial Update: Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 study evaluating exenatide as monotherapy for glucose control in adults with Type 2 diabetes mellitus; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BYETTA (Exenatide)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED